Towards New Therapeutic Solutions for Alpha-1 Antitrypsin Deficiency: Role of the Alpha-1 Foundation.
作者信息
Wanner Adam
机构信息
Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Miller School of Medicine, University of Miami, Miami, Florida.
出版信息
Chronic Obstr Pulm Dis. 2020 Jul;7(3):147-150. doi: 10.15326/jcopdf.7.3.2020.0141.
Abstract
摘要
相似文献
1
Towards New Therapeutic Solutions for Alpha-1 Antitrypsin Deficiency: Role of the Alpha-1 Foundation.寻求α-1抗胰蛋白酶缺乏症的新治疗方案：α-1基金会的作用。
Chronic Obstr Pulm Dis. 2020 Jul;7(3):147-150. doi: 10.15326/jcopdf.7.3.2020.0141.
2
The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult.成人α-1抗胰蛋白酶缺乏症的诊断与管理
Chronic Obstr Pulm Dis. 2016 Jun 6;3(3):668-682. doi: 10.15326/jcopdf.3.3.2015.0182.
3
The Role of Neutrophils in Alpha-1 Antitrypsin Deficiency.中性粒细胞在α-1抗胰蛋白酶缺乏症中的作用
Ann Am Thorac Soc. 2016 Aug;13 Suppl 4:S297-304. doi: 10.1513/AnnalsATS.201509-634KV.
4
The Allergist's Role in Detection of Severe Alpha-1 Antitrypsin Deficiency.过敏症专家在严重α-1 抗胰蛋白酶缺乏症检测中的作用。
J Allergy Clin Immunol Pract. 2017 Sep-Oct;5(5):1302-1306. doi: 10.1016/j.jaip.2017.01.008. Epub 2017 Mar 9.
5
Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.长效 α1-蛋白酶抑制剂治疗 COPD 合并 α1-抗胰蛋白酶缺乏症的长期临床结局：证据分析。
Respir Res. 2017 May 30;18(1):105. doi: 10.1186/s12931-017-0574-1.
6
Characteristics of Alpha-1 Antitrypsin-Deficient Individuals in the Long-term Oxygen Treatment Trial and Comparison with Other Subjects with Chronic Obstructive Pulmonary Disease.长期氧疗试验中α-1抗胰蛋白酶缺乏个体的特征及其与其他慢性阻塞性肺疾病患者的比较。
Ann Am Thorac Soc. 2015 Dec;12(12):1796-804. doi: 10.1513/AnnalsATS.201506-389OC.
7
Recent advances in understanding and treating COPD related to α-antitrypsin deficiency.与α-抗胰蛋白酶缺乏相关的慢性阻塞性肺疾病（COPD）在认识和治疗方面的最新进展。
Expert Rev Respir Med. 2016 Dec;10(12):1281-1294. doi: 10.1080/17476348.2016.1249851. Epub 2016 Nov 4.
8
Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.α-1抗胰蛋白酶缺乏症慢性阻塞性肺疾病患者的主动病例筛查及静脉注射α-1抗胰蛋白酶治疗的指征：最新进展
Arch Bronconeumol. 2015 Apr;51(4):185-92. doi: 10.1016/j.arbres.2014.05.008. Epub 2014 Jul 12.
9
New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency.新型以患者为中心的 α-1 抗胰蛋白酶缺乏症管理方法。
Int J Chron Obstruct Pulmon Dis. 2020 Feb 12;15:345-355. doi: 10.2147/COPD.S234646. eCollection 2020.
10
Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review.α-1抗胰蛋白酶缺乏症所致肺部疾病的治疗：一项系统评价
Int J Chron Obstruct Pulmon Dis. 2017 May 2;12:1295-1308. doi: 10.2147/COPD.S130440. eCollection 2017.
引用本文的文献
1
KF4 Anti-Chymotrypsin-like Elastase 1 Antibody and Purified Alpha-1 Antitrypsin Have Similar but Not Additive Efficacy in Preventing Emphysema in Murine Alpha-1 Antitrypsin Deficiency.KF4抗胰凝乳蛋白酶样弹性蛋白酶1抗体与纯化的α-1抗胰蛋白酶在预防小鼠α-1抗胰蛋白酶缺乏症所致肺气肿方面具有相似但非相加的疗效。
Chronic Obstr Pulm Dis. 2025 Jan 29;12(1):12-22. doi: 10.15326/jcopdf.2024.0535.
2
KF4 anti-CELA1 Antibody and Purified α1-Antitrypsin Have Similar but Not Additive Efficacy in Preventing Emphysema in Murine α1-Antitrypsin Deficiency.KF4抗CELA1抗体和纯化的α1抗胰蛋白酶在预防小鼠α1抗胰蛋白酶缺乏症中的肺气肿方面具有相似但非相加的疗效。
bioRxiv. 2024 May 10:2024.05.07.592994. doi: 10.1101/2024.05.07.592994.
本文引用的文献
1
Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.静脉增强治疗与严重 α1 抗胰蛋白酶缺乏症（RAPID）的肺密度：一项随机、双盲、安慰剂对照试验。
Lancet. 2015 Jul 25;386(9991):360-8. doi: 10.1016/S0140-6736(15)60860-1. Epub 2015 May 27.
Zotero 插件